gabexate has been researched along with Kidney Diseases in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, S | 1 |
| Koide, H | 1 |
| Kobayashi, H | 1 |
| Ohi, H | 1 |
| Kawashima, Y | 1 |
2 other studies available for gabexate and Kidney Diseases
| Article | Year |
|---|---|
[Clinical application of proteinase inhibitors to renal diseases].
Topics: Antithrombins; Esters; Free Radical Scavengers; Gabexate; Guanidines; Humans; Kidney Diseases; Prote | 1991 |
[Prevention of cisplatin induced nephrotoxicity by administering urinastatin to rabbits--comparison with other protease inhibitors].
Topics: Aminopeptidases; Animals; Aprotinin; Cisplatin; Creatinine; Dopamine; Gabexate; gamma-Glutamyltransf | 1989 |